Clinical trial
Compare the Efficacy and Safety Profile of Cysteamine and Hydroquinone in Melasma as Topical Application
NCT05969587 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Efficacy and Safety Profile of Cysteamine and Hydroquinone in Melasma as Topical Application
- Lead sponsor
- China Medical University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 28, 2019
- Completion date
- November 11, 2020
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma